Full Text View
Tabular View
No Study Results Posted
Related Studies
Hämeenlinna Metabolic Syndrome Research Program: Surrogate Indicators for Atherosclerosis (HMS-02)
This study is currently recruiting participants.
Verified May 2010 by Central Hospital of Kanta-Hame
Study NCT01119404   Information provided by Central Hospital of Kanta-Hame

First Received on May 6, 2010.   Last Updated on May 10, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metabolic Syndrome
Coronary Heart Disease
Additional conditions recognized in this trial
Atherosclerosis
Coronary Artery Disease
Coronary Disease
Heart Diseases
Metabolic Syndrome X
Myocardial Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Cardiovascular Diseases
Glucose Metabolism Disorders
Hyperinsulinism
Insulin Resistance
Metabolic Diseases
Vascular Diseases
Sponsors listed in this trial
Central Hospital of Kanta-Hame
Linnan Klinikka, Hämeenlinna, Finland
Mehiläinen Hämeenlinna, Finland
Finnish Red Cross Blood Transfusion Service


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services